South Korea’s CU Medical Systems Inc. has applied for protection of a system that combines features of a cardiopulmonary resuscitation (CPR) device and an automatic external defibrillator (AED) and uses chest impedance measurements to optimize emergency treatment.
New hires and promotions in the med-tech industry, including: Amplity, Amplitude Vascular, Avalere, Beckman Coulter, Femasys, Matica Bio, PHC Holdings.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biosense Webster, Boston Scientific, Graymatters Health.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Autonomix, Bariatek, Body Vision, C2i Genomics, Dnanexus, Element Biosciences, Hugemed, Rehabtronics, Thermo Fisher, Twist Bioscience, Ultrasight, Veracyte, Xlife Sciences.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Qure.ai, Philips, Stimlabs, Zynex.
Researchers from Oregon Health and Science University (OHSU) are seeking patent protection for a transcervical delivery device that may provide clinicians with a simple, inexpensive office-based procedure for the assessment of tubal patency or delivery of a permanent contraceptive agent to the fallopian tube.
A partnership between Gate Neurosciences Inc. and Beacon Biosignals Inc. promises to advance the field of precision psychiatry by using electroencephalogram (EEG) biomarkers to diagnose depression and rapidly assess response to medications. The collaboration will first use Beacon’s U.S. FDA-cleared Dreem 3S headband device and neurobiomarker platform to conduct EEGs in participants in Gate’s phase II trial of zelquistinel, a small-molecule NMDA receptor modulator under development as an antidepressant.
Theryq SAS and Gustave Roussy, a European center for cancer research, were given €38 million (US$40.1 million) in funding by Bpifrance, the French public sector investment bank, to further develop Flashdeep, a flash radiotherapy device that uses extremely high energy electron (VHEE) radiation to treat cancers that are resistant to traditional treatments.
RSS
